CTOs on the Move

Waters Corporation

www.waters.com

 
For fifty years, Waters Corp. has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance. Waters Corp., a publicly traded corporation (NYSE:WAT) headquartered in Milford, Massachusetts, holds worldwide leading positions in complementary analytical technologies - liquid chromatography, mass spectrometry, rheometry and microcalorimetry. These markets account for approximately $5.0 billion of the estimated $20 - $25 billion worldwide analytical instrumentation market. Specifically, the company designs, manufactures, sells and services ultra performance liquid chromatography (UPLC), high performance liquid chromatography (HPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis and rheometry instruments. Waters Corp. operates in ...
  • Number of Employees: 1K-10K
  • Annual Revenue: > $1 Billion
  • www.waters.com
  • 34 Maple St
    Milford, MA USA 01757
  • Phone: 508.478.2000

Executives

Name Title Contact Details
Darren Bernard
Vice President - Corporate MIS Profile

Similar Companies

Canadian Agency for Drugs & Technologies

Canadian Agency for Drugs and Technologies is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Restoration Robotics

Restoration Robotics, Inc., a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system that enables follicular unit extraction.

Del Norte Clinics

Del Norte Clinics is a Yuba City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Makena Medical

Makena Medical is a Laguna Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Acutus Medical

Acutus Medical is committed to pioneering a breakthrough technology to optimize the treatment strategies for complex cardiac arrhythmias by developing innovative, safe, efficacious, and cost-effective solutions for individuals suffering from these complex cardiac arrhythmias. Our mission is to develop and market a platform technology of safe, cost-effective and clinically advanced tools for the minimally invasive diagnosis (mapping) of complex arrhythmias (Atrial Fibrillation and Ventricular Tachycardia) that enable Physicians to optimize treatments and expand the ablation/therapeutic markets. In the pursuit of our mission, we will conduct all of our activities with the highest integrity and strive to become the world’s most valued company within the markets we serve to patients, customers, colleagues, investors, business partners, employees, and the communities in which we work and live.